The effect of serum glucose-to-potassium ratio (GPR) on cerebrovascular diseases has been previously validated. However, the value of the GPR in patients with severe intracerebral hemorrhage (ICH) requiring ICU admission remains unclear. This study aimed to investigate the association between the GPR and the clinical prognosis of critically ill patients with ICH. This study identified patients with severe ICH requiring ICU admission from the Medical Information Mart for Intensive Care (MIMIC-IV) database and divided them into quartiles based on GPR levels. Outcomes included 30-day, 90-day, and 1-year mortality rates. The association between the GPR and clinical outcomes in critically ill patients with ICH was elucidated using Cox proportional hazards regression analysis and restricted cubic splines. In total, 2018 patients (53.8% male), with a median age of 70 years, were enrolled in the study. The 30-day, 90-day, and 1-year mortality rates were 23.9%, 30.1%, and 38.4%, respectively. Per multivariate Cox proportional hazards analysis, an elevated GPR was significantly associated with all-cause mortality. After adjusting for age, sex, Charlson Comorbidity Index, white blood cell count, red blood cell count, platelet count, and Glasgow Coma Scale, patients with an elevated GPR had a higher 30-day mortality (hazard ratio [HR]: 1.32; 95% confidence interval [CI]: 1.22–1.42; P < 0.001), 90-day mortality (HR: 1.27; 95% CI: 1.18–1.37; P < 0.001) and 1-year mortality (HR: 1.22; 95% CI: 1.14–1.31; P < 0.001) when analyzed as a continuous variable. Furthermore, analysis using restricted cubic splines demonstrated a consistent and progressive escalation in the risk of all-cause mortality with an elevated GPR. The GPR was significantly associated with short- and long-term all-cause mortality in critically ill patients with ICH. This finding demonstrates that GPR may be useful in identifying patients with ICH at a high risk of all-cause mortality.
28 April 2025 in Journal of Medical Internet Research
Background: Sepsis is a life-threatening condition frequently observed in patients with intracerebral hemorrhage (ICH) who are critically ill. Early and accurate identification and prediction of sepsis are crucial. Machine learning (ML)–based predictive models exhibit promising sepsis prediction capabilities in emergency settings. However, their application in predicting sepsis among patients with ICH is still limited. Objective: The aim of the study is to develop an ML-driven risk calculator for early prediction of sepsis in patients with ICH who are critically ill and to clarify feature importance and explain the model using the Shapley Additive Explanations method. Methods: Patients with ICH admitted to the intensive care unit (ICU) from the Medical Information Mart for Intensive Care IV database between 2008 and 2022 were divided into training and internal test sets. The external test was performed using the eICU Collaborative Research Database, which includes over 200,000 ICU admissions across the United States between 2014 and 2015. Sepsis following ICU admission was identified using Sepsis-3.0 through clinical diagnosis combining elevation of the Sequential Organ Failure Assessment by ≥2 points with suspected infection. The Boruta algorithm was used for feature selection, confirming 29 features. Nine ML algorithms were used to construct the prediction models. Predictive performance was compared using several evaluation metrics, including the area under the receiver operating characteristic curve (AUC). The Shapley Additive Explanations technique was used to interpret the final model, and a web-based risk calculator was constructed for clinical practice. Results: Overall, 2414 patients with ICH were enrolled from the Medical Information Mart for Intensive Care IV database, with 1689 and 725 patients assigned to the training and internal test sets, respectively. An external test set of 2806 patients with ICH from the eICU database was used. Among the 9 ML models tested, the categorical boosting (CatBoost) model demonstrated the best discriminative ability. After reducing features based on their importance, an explainable final CatBoost model was developed using 8 features. The final model accurately predicted sepsis in internal (AUC=0.812) and external (AUC=0.771) tests. Conclusions: We constructed a web-based risk calculator with 8 features based on the CatBoost model to assist clinicians in identifying people at high risk for sepsis in patients with ICH who are critically ill.
1 September 2024 in International Journal of General Medicine
Background and Aims: The red blood cell distribution width (RDW) to albumin (ALB) ratio (RAR) has been identified as a prognostic indicator for mortality in critically ill patients across various diseases. Nevertheless, the impact of RAR on clinical functional prognosis in Acute ischemic stroke (AIS) remains uncertain. This study aimed to evaluate the prognostic significance of RAR in AIS patients. Methods: A secondary analysis was performed on a cohort study, involving 1906 AIS patients recruited from a South Korean academic hospital. Both univariate and multivariate logistic regression was employed to assess the connections between RAR and negative functional results in AIS. To explore potential non-linear relationships in this association, a generalized additive model (GAM) and smooth curve fitting were utilized. Further, a mediation analysis was performed to identify possible mediators. Results: Out of the 1906 eligible patients, 546 (28.65%) were found to have an unfavorable prognosis. Patients with elevated RAR had a higher likelihood of facing a negative prognosis in AIS (all P< 0.001). RAR demonstrated a dose-response relationship with the probability of poor functional prognosis. When analysis of RAR as a continuous variable, an increase in RAR was correlated with a higher risk of adverse prognosis.When RAR was analyzed as quartile variables, the highest RAR remained an independent contributing factor for both 3-month unfavorable outcomes (adjusted OR, 1.4; 95% CI: 1.0– 2.1, P=0.046) and 3-month mortality (adjusted OR, 5.2; 95% CI, 2.0– 13.9; p< 0.001). More interestingly, the presence of a pro-inflammatory state may serve as a mediator in the connections between RAR and adverse functional outcomes. Conclusion: Given its cost-effectiveness and ease of measurement, baseline RAR holds promise as a valuable biomarker for early risk assessment in AIS patients.
Introduction: This study aimed to assess the correlation between the blood urea nitrogen (BUN)-to-creatinine (BUN/Cr) ratio and adverse outcomes (AOs) at 3 months in patients with acute ischemic stroke (AIS) in the Korean population.Methods: This cohort study encompassed 1906 cases of AIS at a South Korean hospital from January 2010 to December 2016. To determine the linear correlation between the BUN/Cr ratio and AOs in AIS, a binary logistic regression model (BLRM) was employed. Additionally, generalized additive models and techniques for smooth curve fitting were utilized to reveal the nonlinear dynamics between the BUN/Cr ratio and AOs in patients with AIS.Results: The prevalence of AOs was 28.65%, with a median BUN/Cr ratio of 18.96. Following adjustments for covariates, the BLRM disclosed that the association between the BUN/Cr ratio and the risk of AOs in patients with AIS did not attain statistical significance. Nevertheless, a nonlinear relationship surfaced, pinpointing an inflection point at 21.591. To the left of this inflection point, a 31.42% reduction in the risk of AOs was noted for every 1-unit surge in the Z score of the BUN/Cr ratio [odds ratio (OR) = 0.686, 95% confidence interval (CI): 0.519, 0.906, p = 0.008]. On the right side of the inflection point, the effect size (OR = 1.405, 95% CI: 1.018, 1.902, p = 0.039) was determined.Conclusion: The findings of this study underscore the intricate nature of the relationship between the BUN/Cr ratio and 3-month outcomes in patients with AIS, establishing a robust groundwork for future investigations.
Objectives Stroke is a major cause of death and disability globally, especially among diabetic patients. In this study, we aim to scrutinise the effects of metformin on the clinical outcomes of stroke in diabetic patients. Design This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data sources PubMed, Embase and Web of Science databases were searched between their inception and 5 December 2023. Eligibility criteria for selecting studies Studies investigating the effect of metformin on the clinical outcomes of stroke in patients with diabetes were included. Data extraction and synthesis The effect of metformin on the clinical outcomes of stroke in patients with diabetes was identified using combined ORs and 95% CIs. Results A total of 11 studies involving 18 525 participants were included in this review. Pooled analysis has demonstrated that prestroke metformin use could reduce the probability of poor course after stroke by 34% in diabetes mellitus (DM) patients (OR=0.66, 95% CI: 0.61 to 0.72) and reduce the probability of death by 43% (OR=0.57, 95% CI: 0.51 to 0.64). Conclusions Prestroke metformin use is beneficial for the improvement of clinical outcomes in patients who had a stroke with DM, although the potential bias should be carefully considered. PROSPERO registration number CRD42024496056.
7 January 2009 in Instrumentation Science & Technology
To investigate the pharmacokinetic characteristics of a novel nanoliposome-entrapped docetaxel injection, an anti-tumor agent, a high-throughput analytical method based on liquid chromatography with positive ion electrospray ionization (ESI) coupled to tandem mass spectrometry detection (LC-MS/MS) was developed for the determination of docetaxel in beagle dog plasma using paclitaxel as the internal standard (I.S.). Most liquid transfer steps, including preparation of calibration standards and quality control samples, as well as the addition of the I.S., were performed by using eight-channel pipetting tools. The analyte and internal standard were isolated from 50 µL plasma samples and chromatographed on a Ultimate XB C-8 column (50 mm × 4.6 mm, 5 µm) with a mobile phase consisting of methanol–water–formic acid (90:10:0.01, v/v/v)pumped at 0.3 mL/min. The method had a chromatographic total run time of 3 min. A Varian 1200 L electrospray tandem mass spectrometer equipped with an electrospray ionization source was operated in selected reaction monitoring (SRM) mode with the precursor-to-product ion transitions m/z 830.0 → 549.0 (docetaxel) and 876.0 → 591.0 (paclitaxel) used for quantitation. The method was sensitive, with a lower limit of quantitation (LLOQ) of 1 ng/mL and good linearity in the range 1–500 ng/mL for docetaxel. All the validation data, such as accuracy, precision, and inter-day repeatability, were within the required limits. The method was successfully applied to initial pharmacokinetic study of nanoliposome-entrapped docetaxel injection in beagle dogs, and the statistical results of the pharmacokinetic data clearly suggest the novel formulation vehicle does control docetaxel's acute side effects to some extent.